Cart
sales@molnova.com
Methyl tanshinonate
CAS No. 18887-19-9
Methyl tanshinonate( —— )
Catalog No. M31162 CAS No. 18887-19-9
Methyl tanshinonate has antioxidant activity, it can treat psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 486 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethyl tanshinonate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyl tanshinonate has antioxidant activity, it can treat psoriasis.
-
DescriptionMethyl tanshinonate has antioxidant activity, it can treat psoriasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18887-19-9
-
Formula Weight338.35
-
Molecular FormulaC20H18O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2,6-Dimethoxybenzoic...
2, 6-Dimethoxybenzoic acid is an active biochemical.
-
10-Deacetylcephaloma...
The barks of Cephalotaxus sinensis.
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.
